Association of anti-porphyromonas gingivalis antibody titers with nonsmoking status in early rheumatoid arthritis: Results from the prospective French cohort of patients with early rheumatoid arthritis

Arthritis and Rheumatology

Volumn 67, Issue 7, 2015, Pages 1729-1737

  Seror, Raphaèle ^a   Le Gall David, Sandrine ^b   Bonnaure Mallet, Martine ^b   Schaeverbeke, Thierry ^c   Cantagrel, Alain ^d   Minet, Jacques ^b   Gottenberg, Jacques Eric ^e   Chanson, Philippe ^f   Ravaud, Philippe ^g   Mariette, Xavier ^a  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BETA 2 MICROGLOBULIN; CITRULLINATED PROTEIN ANTIBODY; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; PROTEIN ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; ANTIIDIOTYPIC ANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; HEREDITY; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PORPHYROMONAS GINGIVALIS INFECTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SMOKING; ADVERSE EFFECTS; ARTHRITIS, RHEUMATOID; BACTEROIDACEAE INFECTION; BLOOD; CASE CONTROL STUDY; COMORBIDITY; COMPLICATION; ENVIRONMENT; FRANCE; IMMUNOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; BACTEROIDACEAE INFECTIONS; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; ENVIRONMENT; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PORPHYROMONAS GINGIVALIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 84933059998     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39118     Document Type: Article

References (31)

1. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, et al, and the Epidemiological Investigation of Rheumatoid Arthritis Study Group. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38-46.
2. De Pablo P, Dietrich T, McAlindon TE., Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008; 35: 70-6.
3. Chen HH, Huang N, Chen YM, Chen TJ, Chou P, Lee YL, et al., Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann Rheum Dis 2013; 72: 1206-11.
4. Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, et al., Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012; 64: 3083-94.
5. Potikuri D, Dannana KC, Kanchinadam S, Agrawal S, Kancharla A, Rajasekhar L, et al., Periodontal disease is significantly higher in non-smoking treatment-naive rheumatoid arthritis patients: results from a case-control study. Ann Rheum Dis 2012; 71: 1541-4.
6. Mercado FB, Marshall RI, Klestov AC, Bartold PM., Relationship between rheumatoid arthritis and periodontitis. J Periodontol 2001; 72: 779-87.
7. Pischon N, Pischon T, Kroger J, Gulmez E, Kleber BM, Bernimoulin JP, et al., Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol 2008; 79: 979-86.
8. Demmer RT, Molitor JA, Jacobs DR Jr, Michalowicz BS., Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. J Clin Periodontol 2011; 38: 998-1006.
9. Hajishengallis G, Darveau RP, Curtis MA., The keystone-pathogen hypothesis. Nat Rev Microbiol 2012; 10: 717-25.
10. Mikuls TR, Payne JB, Reinhardt RA, Thiele GM, Maziarz E, Cannella AC, et al., Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol 2009; 9: 38-42.
11. Hitchon CA, Chandad F, Ferucci ED, Willemze A, Ioan-Facsinay A, van der Woude D, et al., Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 2010; 37: 1105-12.
12. Okada M, Kobayashi T, Ito S, Yokoyama T, Komatsu Y, Abe A, et al., Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults. J Periodontol 2011; 82: 1433-41.
13. Arvikar SL, Collier DS, Fisher MC, Unizony S, Cohen GL, McHugh G, et al., Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis. Arthritis Res Ther 2013; 15: R109.
14. Mikuls TR, Thiele GM, Deane KD, Payne JB, O'Dell JR, Yu F, et al., Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 2012; 64: 3522-30.
15. Smit MD, Westra J, Vissink A, Doornbos-van der Meer B, Brouwer E, van Winkelhoff AJ., Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther 2012; 14: R222.
16. Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, et al., Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 2014; 66: 1090-100.
17. Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daures JP, Dougados M, et al., The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007; 74: 440-5.
18. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al., 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
19. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL., Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
20. Fries JF, Spitz P, Kraines RG, Holman HR., Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
21. Gottenberg JE, Dayer JM, Lukas C, Ducot B, Chiocchia G, Cantagrel A, et al., Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis 2012; 71: 1243-8.
22. Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X., Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis Res Ther 2009; 11: R114.
23. Van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB., Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995; 22: 1792-6.
24. Tobon G, Saraux A, Lukas C, Gandjbakhch F, Gottenberg JE, Mariette X, et al., First-year radiographic progression as a predictor of further progression in early arthritis: results of a large national French cohort. Arthritis Care Res (Hoboken) 2013; 65: 1907-15.
25. Kaur S, White S, Bartold PM., Periodontal disease and rheumatoid arthritis: a systematic review. J Dent Res 2013; 92: 399-408.
26. Quirke AM, Lugli EB, Wegner N, Hamilton BC, Charles P, Chowdhury M, et al., Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis 2014; 73: 263-9.
27. Konig MF, Paracha AS, Moni M, Bingham CO III, Andrade F., Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology. Ann Rheum Dis 2014. E-pub ahead of print.
28. Brink M, Hansson M, Ronnelid J, Klareskog L, Rantapaa Dahlqvist S., The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Antibodies against uncitrullinated peptides seem to occur prior to the antibodies to the corresponding citrullinated peptides. Ann Rheum Dis 2014; 73: e46.
29. De Pablo P, Dietrich T, Chapple IL, Milward M, Chowdhury M, Charles PJ, et al., The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Ann Rheum Dis 2014; 73: 580-6.
30. Lappin DF, Apatzidou D, Quirke AM, Oliver-Bell J, Butcher JP, Kinane DF, et al., Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol 2013; 40: 907-15.
31. Kaur S, Bright R, Proudman SM, Bartold PM., Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Semin Arthritis Rheum 2014; 44: 113-22.